ArticleFrontiers in endocrinology2020

The Atypical Cannabinoid Abn-CBD Reduces Inflammation and Protects Liver, Pancreas, and Adipose Tissue in a Mouse Model of Prediabetes and Non-alcoholic Fatty Liver Disease.

Silvana Y Romero-Zerbo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.